Trygg Pharma Overview

  • Founded
  • 2009

  • Status
  • Out of Business

  • Employees
  • 23

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 4

  • Investments
  • 2

Trygg Pharma General Information


Operator of a pharmaceutical enterprise focused on developing omega-3 fatty acids. The company engages in biotechnological research and development, manufacturing and selling of marine-based omega-3 fatty acid concentrate to the nutritional supplements market.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Primary Industry
Other Industries
Primary Office
  • Fjordalléen 16
  • 0115 Oslo
  • Norway

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trygg Pharma Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Trygg Pharma‘s full profile, request access.

Request a free trial

Trygg Pharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trygg Pharma Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 000 01-Jan-2018 000000000 0000 Pharmaceuticals
Epax 01-Dec-2010 Buyout/LBO 000.00 Pharmaceuticals 00000 000
To view Trygg Pharma’s complete investments history, request access »

Trygg Pharma Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 00000000 01-Jan-2018 000000000 0000 Completed
  • 00000 000000
Epax 01-Dec-2010 Buyout/LBO 000.00 Completed
  • 3 buyers
To view Trygg Pharma’s complete exits history, request access »